All Stories

  1. Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit
  2. Pharmacokinetic profiles of the active metamizole metabolites in healthy horses
  3. Pharmacokinetic investigations of the marker active metabolites 4-methylamino-antipyrine and 4-amino-antipyrine after intramuscular injection of metamizole in healthy piglets
  4. Pharmacokinetic profiles of the analgesic flupirtine in dogs after the administration of four pharmaceutical formulations
  5. Pharmacokinetic/pharmacodynamic assessments of 10 mg/kg tramadol intramuscular injection in yellow-bellied slider turtles (Trachemys scripta scripta)
  6. Pharmacokinetics of tramadol and its major metabolite after intramuscular administration in piglets
  7. Use of the novel atypical opioid tapentadol in goats (Capra hircus): pharmacokinetics after intravenous, and intramuscular administration
  8. Detection and quantification of cimicoxib, a novel COX-2 inhibitor, in canine plasma by HPLC with spectrofluorimetric detection: Development and validation of a new methodology
  9. Pharmacokinetics of Sulpiride After Intravenous, Intramuscular, and Oral Single-Dose Administration in Nurse Mares
  10. Pharmacokinetics of Mirtazapine and Its Main Metabolites after Single Oral Administration in Fasting/Fed Horses
  11. Biocompatibility of boron nitride nanotubes: An up-date of in vivo toxicological investigation
  12. Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs
  13. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs
  14. Development and Validation of a New GC-MS Method for the Detection of Tramadol, O-Desmethyltramadol, 6-Acetylmorphine and Morphine in Blood, Brain, Liver and Kidney of Wistar Rats Treated with the Combination of Heroin and Tramadol
  15. Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: Development and validation of a new methodology
  16. Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles
  17. New HPLC Method to Detect Individual Opioids (Heroin and Tramadol) and their Metabolites in the Blood of Rats on Combination Treatment
  18. Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: A pilot study
  19. Inulin-Based Hydrogel for Oral Delivery of Flutamide: Preparation, Characterization, and in vivo Release Studies
  20. ABNORMAL FINDINGS IN HAEMOGRAMS OF DACHSHUND PUPPIES: PRESUMPTIVE (IMMUNODEFICIENCY) FAMILIAL DISEASE
  21. Pilot in vivo toxicological investigation of boron nitride nanotubes
  22. Quantification of Zolpidem in Canine Plasma
  23. Mirtazapine in Veterinary Medicine a Pharmacological Rationale for its Application in Chronic Pain
  24. Oral administration of tepoxalin in the horse: A PK/PD study
  25. Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in Beagle dogs
  26. Characterization of in vivo plasma metabolites of tepoxalin in horses using LC–MS–MS
  27. First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study
  28. Pharmacokinetics of tramadol and metabolites after injective administrations in dogs
  29. Determination of tramadol and metabolites by HPLC-FL and HPLC–MS/MS in urine of dogs
  30. Pharmacokinetics of methylphenidate following two oral formulations (immediate and sustained release) in the dog
  31. PK-PD integration / modeling of NSAID in veterinary pharmacology
  32. Pharmacokinetics of Tramadol after Epidural Administration in Horses
  33. Evaluation of Plasma Detectable Concentrations of Two Lidocaine Transdermal Formulations and Their Analgesic Effect in the Horse
  34. Pharmacokinetics of Tramadol and Its Metabolites M1, M2, and M5 in Donkeys after Intravenous and Oral Immediate Release Single-Dose Administration
  35. High performance liquid chromatographic determination of thalidomide in patients affected by hepatocellular carcinoma
  36. Pharmacokinetics of Tramadol and its Metabolites M1, M2 and M5 in Horses Following Intravenous, Immediate Release (Fasted/Fed) and Sustained Release Single Dose Administration
  37. Inhibition of cytochrome P450 enzymes by enrofloxacin in the sea bass (Dicentrarchus labrax)
  38. Effects of β-naphthoflavone on the cytochrome P450 system, and phase II enzymes in gilthead seabream (Sparus aurata)